Credit Suisse’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $421K | Buy |
|
|||||
|
2023
Q4 | $347K | Sell |
|
|||||
|
2023
Q3 | $394K | Sell |
|
|||||
|
2023
Q2 | $565K | Buy |
|
|||||
|
2023
Q1 | $119K | Buy |
|
|||||
|
2022
Q4 | $173K | Buy |
|
|||||
|
2022
Q3 | $120K | Buy |
|
|||||
|
2022
Q2 | $88K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $271K | Buy |
|
|||||
|
2021
Q2 | $224K | Buy |
|
|||||
|
2021
Q1 | $202K | Sell |
|
|||||
|
2020
Q4 | $264K | Buy |
|